CoChat

Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy: Rasch Analysis of NSAA in DMD

Open access
MAYHEW, ANNA, CANO, STEFAN, SCOTT, ELAINE, EAGLE, MICHELLE, BUSHBY, KATE, MUNTONI, FRANCESCO, ON BEHALF OF THE NORTH STAR CLINICAL NETWORK FOR PAEDIATRIC NEUROMUSCULAR DISEASE · 2011 · Developmental Medicine & Child Neurology
Cited by 130

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

AIM: Reliable measurement of disease progression and the effect of therapeutic interventions in Duchenne muscular dystrophy (DMD) require clinically meaningful and scientifically sound rating scales. Therefore, we need robust evidence to support such tools. The North Star Ambulatory Assessment (NSAA) is a promising, clinician-rated scale with potential uses spanning clinical practice and clinical trials. In this study, we used Rasch analysis to test its suitability in these roles as a measurement instrument. METHOD: NSAA data from 191 ambulant boys (mean age at assessment 7 y 8 mo, SD 2 y 4 mo; range 3 y 6 mo-15 y 5 mo) with a confirmed diagnosis of DMD were examined for psychometric properties including clinical meaning, targeting, response categories, model fit, reliability, dependency, stability, and raw to interval-level measurement. All analyses were performed using the Rasch Unidimensional Measurement Model. RESULTS: Overall, Rasch analysis supported the NSAA as being a reliable (high Person Separation Index of 0.91) and valid (good targeting, little misfit, no reversed thresholds) measure of ambulatory function in DMD. One item displayed misfit (lifts head, fit residual 6.9) and there was evidence for some local dependency (stand on right/left leg, climb and descend box step right/left leg, and hop on right/left leg, residual correlations >0.40), which we provide potential solutions for in future use of the NSAA. Importantly, our findings supported good clinical validity in that the hierarchy of items within the scale produced by the analyses was supported by clinical opinion, thus increasing the clinical interpretability of scale scores. INTERPRETATION: In general, Rasch analysis supported the NSAA as a psychometrically robust scale for use in DMD clinical research and trials. This study also demonstrates how Rasch analysis is a useful instrument to detect and understand the key measurement issues of rating scales.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1469-8749.2011.03939.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 24

  1. Drousiotou, 1998, Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus, Genet Test, 2, 55, 10.1089/gte.1998.2.55 · DOI
  2. Bradley, 1998, Newborn screening for Duchenne muscular dystrophy, Semin Neonatol, 3, 27, 10.1016/S1084-2756(98)80146-2 · DOI
  3. Emery, 1991, Population frequencies of inherited neuromuscular diseases - a world survey, Neuromuscul Disord, 1, 19, 10.1016/0960-8966(91)90039-U · DOI · Paper page
  4. Bushby, 2010, Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, pharmacological and psychosocial management, Lancet Neurol, 9, 77, 10.1016/S1474-4422(09)70271-6 · DOI · Paper page
  5. Manzur, 2008, Glucocorticoid corticosteroids for Duchenne muscular dystrophy, Cochrane Database Syst Rev, 1, CD003725
  6. Scott, 2006, The North Star Ambulatory Assessment. Poster presented at the Annual Meeting of the British Paediatric Neurology Association, 2006, Dev Med Child Neurol, 48, 27
  7. Kinali, 2009, Local restoration of dystrophin expression in Duchenne muscular dystrophy: a single blind, placebo-controlled dose escalation study using morpholino antisense oligomer AVI-4658, Lancet Neurol, 8, 918, 10.1016/S1474-4422(09)70211-X · DOI · Paper page
  8. Shrewsbury, 2010, Current progress and preliminary results with the systematic administration trial of AVI-4658, a novel phosophorodiamidate morpholino oligomer (PMO) skipping dystrohin exon 51 in Duchenne muscular dystrophy (DMD) World Muscle Society Meeting, Kumamoto, Japan 12-16th October, 2010, Neuromuscul Disord, 20, 639, 10.1016/j.nmd.2010.07.140 · doi:10.1016/j.nmd.2010.07.140
  9. Cano, 2008, Watch out, watch out, the FDA are about, Dev Med Child Neurol, 50, 408, 10.1111/j.1469-8749.2008.00408.x · DOI
  10. Novick, 1966, The axioms and principal results of classical test theory, J Math Psychol, 3, 1, 10.1016/0022-2496(66)90002-2 · DOI · Paper page
  11. Wright, 1989, Observations are always ordinal: measurements, however must be interval, Arch Phys Med Rehabil, 70, 857
  12. Wright, 1979, Best Test Design: Rasch Measurement
  13. Mazzone, 2009, Reliability of the North Star Ambulatory Assessment in a multicentric setting, Neuromuscul Disord, 19, 458, 10.1016/j.nmd.2009.06.368 · DOI · Paper page
  14. Rasch, 1960, Probabilistic Models for Some Intelligence and Attainment Tests
  15. Wright, 1982, Rating Scale Analysis: Rasch Measurement
  16. Hobart, 2006, Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88), Brain, 129, 224, 10.1093/brain/awh675 · DOI · Paper page
  17. Hagquist, 2004, Is the Sense of Coherence instrument applicable on adolescents? A latent trait analysis using Rasch modelling, Pers Individ Diff, 36, 955, 10.1016/S0191-8869(03)00164-8 · DOI
  18. Andrich, 1989, Proceedings of the XXIVth International Congress of Psychology, 7
  19. Cronbach, 1951, Coefficient alpha and the internal structure of tests, Psychometrika, 16, 297, 10.1007/BF02310555 · DOI · Paper page
  20. RUMM Laboratory, 19972007, RUMM2020, Version 4.0 for Windows (Upgrade 4600.0109)
  21. Scott, 1981, Prevention of deformity in Duchenne muscular dystrophy. A prospective study of passive stretching and splintage, Physiotherapy, 67, 177
  22. Hyde, 2000, A randomized comparative study of two methods for controlling tendo achilles contracture in Duchenne muscular dystrophy, Neuromuscul Disord, 10, 257, 10.1016/S0960-8966(99)00135-2 · DOI
  23. Steffensen, 2001, Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy, Physiother Res Int, 6, 119, 10.1002/pri.221 · doi:10.1002/pri.221
  24. Steffensen, 2002, Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study, Dev Med Child Neurol, 44, 623, 10.1111/j.1469-8749.2002.tb00847.x · doi:10.1111/j.1469-8749.2002.tb00847.x

Cited by

See all 130

Metadata

Authors
MAYHEW, A., CANO, S., SCOTT, E., EAGLE, M., BUSHBY, K., MUNTONI, F., & ON BEHALF OF THE NORTH STAR CLINICAL NETWORK FOR PAEDIATRIC NEUROMUSCULAR DISEASE
Venue
Developmental Medicine & Child Neurology
Publisher
Wiley
Published
2011-03-17
Volume
53
Issue
6
Pages
535-542
ISSN
0012-1622 (ISSN-L)
OpenAlex
W1496452409
Cited by
130
References
3
FWCI
15.17
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1629 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy: Rasch Analysis of NSAA in DMD. https://app.cochat.ai/papers/10.1111/j.1469-8749.2011.03939.x
The paper
MAYHEW, A., CANO, S., SCOTT, E., EAGLE, M., BUSHBY, K., MUNTONI, F., & ON BEHALF OF THE NORTH STAR CLINICAL NETWORK FOR PAEDIATRIC NEUROMUSCULAR DISEASE. (2011). Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy: Rasch Analysis of NSAA in DMD. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.03939.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.